Close

AES Clean Technology Accelerates Cleanroom Capabilities with $14.2 million Investment

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

API China, PHARMCHINA & NHNE 2025 Conclude with Global Win

API China, PHARMCHINA & NHNE 2025 Close in Guangzhou...

Under-Eye Wrinkle Treatment: How to Reduce Puffiness and Fine Lines

As we age, the skin around our eyes begins...

Receptor Grade IGF-1 LR3: Expansive Research Potential

Receptor Grade IGF-1 LR3, an engineered analog of Insulin-like...

API China 2025 kicks off with Industry Buzz on Day One

At the China Import and Export Fair Complex in...

AES Clean Technology, a leading provider of high-performance cleanroom facilities within the pharmaceutical and bio-pharmaceutical industry, announced a $14.2 million investment to open a new manufacturing facility located in Manheim Borough, Lancaster County, Pennsylvania.

The new state-of-the-art facility will see 97 full-time jobs created and will serve as a manufacturing hub for its modular cleanroom systems. As part of the project, AES will carry out building renovations, purchase the latest production technologies to manufacture its cleanroom products, and train new employees.

This new manufacturing site will be phased into operation in the coming year and will compliment AES’ existing manufacturing capabilities in Suwanee, GA, and will further expand AES’ production capabilities to match industry growth, particularly from those clients responsible for the manufacturing of COVID-19 treatments and advanced bio-therapeutics.

Grant Merrill, CEO of AES Clean Technology commented, ”We are proud to expand upon our 35-year presence in the Commonwealth of Pennsylvania as we continue the mission of helping our pharmaceutical and biotechnology clients save lives through the therapies that they manufacture inside our cleanroom facilities.”

“It’s an important factor to us, and our customers, that we directly control the manufacturing of these critical cleanroom systems. This investment is evidence of our ongoing commitment to controlling all aspects of the supply chain as we bring cleanroom facilities to life for our clients.”

The company will retain the existing 95 jobs at its headquarters in Montgomery County and current manufacturing operations in Suwanee, GA.

Latest stories

Related stories

API China, PHARMCHINA & NHNE 2025 Conclude with Global Win

API China, PHARMCHINA & NHNE 2025 Close in Guangzhou...

Under-Eye Wrinkle Treatment: How to Reduce Puffiness and Fine Lines

As we age, the skin around our eyes begins...

Receptor Grade IGF-1 LR3: Expansive Research Potential

Receptor Grade IGF-1 LR3, an engineered analog of Insulin-like...

API China 2025 kicks off with Industry Buzz on Day One

At the China Import and Export Fair Complex in...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back